蔡管辅助腹腔镜自然腔道取标本结肠切除术治疗左半结肠癌的前瞻性随机试验临床结局
该前瞻性随机试验将60例左半结肠癌患者随机分为LA-NOSE组和传统腹腔镜组,每组30例。LA-NOSE组借助蔡管经肛取出标本。结果显示LA-NOSE组术后最大疼痛评分和额外镇痛需求显著更低,排气时间更短,而手术时间、出血量、住院时间、并发症、淋巴结清扫数量和切缘状态及长期结局两组无显著差异。
要点
- LA-NOSE联合蔡管可降低左半结肠癌术后疼痛和镇痛需求。
- LA-NOSE组胃肠功能恢复更快,排气时间更短。
- 两组手术安全性、病理质量和长期肿瘤学结局相似。
核心结论
- 对于左半结肠癌,使用蔡管的LA-NOSE结肠切除术相比传统腹腔镜结肠切除术术后疼痛更轻、胃肠功能恢复更快,且长期结局相似。
研究设计与样本
- 前瞻性随机试验,2015年3月至2017年8月纳入60例左半结肠癌患者,LA-NOSE组和传统腹腔镜组各30例。
主要发现
- LA-NOSE组术后最大疼痛评分显著低于传统腹腔镜组(均值2.5 vs. 5.1,P=0.001)。
- LA-NOSE组额外镇痛需求显著少于传统腹腔镜组(均值2/30 vs. 10/30,P=0.021)。
- LA-NOSE组首次排气时间显著短于传统腹腔镜组(均值2.2 vs. 3.1天,P=0.026)。
- 两组手术时间、出血量、术后住院时间、手术并发症率、淋巴结清扫数量及切缘状态无显著差异。
- 中位随访48个月(范围7-59个月),两组长期结局(3年总生存率、无病生存率、局部复发和总体复发)无差异。
关键数值与推荐
- LA-NOSE组经肛借助蔡管(专利号ZL201410168748.2)取出标本。
- 主要结局指标为术后疼痛,次要结局包括手术时间、术后恢复、手术并发症、标本病理质量及长期结局。
- 所有患者术后6个月均可控制排便。
临床怎么用
- 在左半结肠癌手术中,可考虑采用蔡管辅助LA-NOSE以减轻术后疼痛并加速胃肠功能恢复。
- 该技术未增加手术时间、出血量、并发症或影响病理质量及长期肿瘤学结局。
局限性
- 样本量较小(共60例),可能影响统计效能。
- 为单中心研究,结果外推需谨慎。
- 随访时间有限(中位48个月),长期肿瘤学结局需更长时间验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The role of laparoscopic-assisted natural orifice specimen extraction (LA-NOSE) colectomy in the treatment of left-sided colon cancer has not been well defined, and there remains confusion about how to conveniently exteriorize specimens through natural orifices. Therefore, we introduced a homemade invention, the Cai tube, to facilitate the extraction of specimens and compared the clinical outcomes of LA-NOSE with conventional laparoscopic (CL) colectomy for left-sided colon cancer. METHODS: From March 2015 to August 2017, patients with left-sided colon cancer were randomly divided into LA-NOSE and CL groups. Specimens were extracted through the anus with the help of a Cai tube (Patent Number: ZL201410168748.2) in the LA-NOSE group. The primary outcome measure was postoperative pain. Secondary outcomes were the duration of operation, postoperative recovery, surgical morbidity, pathological quality of the specimen, and long-term outcomes, including 3-year overall survival, disease-free survival, local recurrence, and overall recurrence. RESULTS: A total of 60 patients (30 per group) were recruited for this study. None of the patients required emergency conversion to conventional laparoscopic or open surgery during the operation. The postoperative maximum pain score was significantly lower in the LA-NOSE group (mean 2.5 vs. 5.1, P = 0.001), as was the additional analgesia requirement (mean 2/30 vs. 10/30, P = 0.021). Patients in the LA-NOSE group experienced a shorter first time to passage of flatus (mean 2.2 vs. 3.1 days, P = 0.026). All patients could control their defecation at 6 months after surgery. The comparison between the two groups showed no significant differences in the operative time, bleeding volume, postoperative hospital stay, surgical morbidity rates, number of lymph nodes harvested, or resection margin status. The mean follow-up was 48 months (range 7-59) and was similar in both groups. The results showed no differences in long-term outcomes between the two groups. CONCLUSION: In the treatment of left-sided colon cancer, compared with conventional laparoscopic colectomy, LA-NOSE colectomy using the Cai tube exhibited lower postoperative pain, shorter recovery of gastrointestinal function, and similar long-term outcomes. REGISTRATION NUMBER: ChiCTR-OOR-15007060 ( http://www.chictr.org.cn/ ).
引用
- Xu SZ, Ding ZJ, Zhang SF, et al. Clinical outcomes of laparoscopic-assisted natural orifice specimen extraction colectomy using a Cai tube for left-sided colon cancer: a prospective randomized trial. Surg Endosc. 2022. PMID: 35906459. doi:10.1007/s00464-022-09435-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。